BIOMERICA INC Operating Lease, Right-of-Use Asset, Amortization Expense
BIOMERICA INC (BMRA) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $344.00 thousand for the 12-month period ending 2026-05-31, per its 10-K filed 2026-08-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-31
- BIOMERICA INC operating lease, right-of-use asset, amortization expense for the quarter ending 2026-05-31 was $94.00K, a 16.05% increase year-over-year.
- BIOMERICA INC operating lease, right-of-use asset, amortization expense for the quarter ending 2026-02-28 was $85.00K, a 8.97% increase year-over-year.
- BIOMERICA INC operating lease, right-of-use asset, amortization expense for the quarter ending 2025-11-30 was $83.00K, a 6.41% increase year-over-year.
- BIOMERICA INC operating lease, right-of-use asset, amortization expense for the quarter ending 2025-08-31 was $82.00K, a 7.89% increase year-over-year.
- BIOMERICA INC operating lease, right-of-use asset, amortization expense for fiscal 2026 was $344.00K, a 9.90% increase from fiscal 2025.
- BIOMERICA INC operating lease, right-of-use asset, amortization expense for fiscal 2025 was $313.00K, a 6.83% increase from fiscal 2024.
- BIOMERICA INC operating lease, right-of-use asset, amortization expense for fiscal 2024 was $293.00K, a 9.74% increase from fiscal 2023.
- BIOMERICA INC operating lease, right-of-use asset, amortization expense for fiscal 2023 was $267.00K, a 4.30% increase from fiscal 2022.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month as first filed | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month as first filed | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month as first filed | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-05-31 | $94.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-31 | $179.00K derived: sum of 2 quarters · filed 2026-08-31 | $262.00K derived: sum of 3 quarters · filed 2026-08-31 | $344.00K 10-K · filed 2026-08-31 | ||||
| 2026-02-28 | $85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-13 | $168.00K derived: sum of 2 quarters · filed 2026-04-13 | $250.00K 10-Q · filed 2026-04-13 | $331.00K derived: sum of 4 quarters · filed 2026-08-31 | ||||
| 2025-11-30 | $83.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-14 | $165.00K 10-Q · filed 2026-01-14 | $246.00K derived: sum of 3 quarters · filed 2026-08-31 | $324.00K derived: sum of 4 quarters · filed 2026-08-31 | ||||
| 2025-08-31 | $82.00K 10-Q · filed 2025-10-14 | $163.00K derived: sum of 2 quarters · filed 2026-08-31 | $241.00K derived: sum of 3 quarters · filed 2026-08-31 | $319.00K derived: sum of 4 quarters · filed 2026-08-31 | ||||
| 2025-05-31 | $81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-31 | $159.00K derived: sum of 2 quarters · filed 2026-08-31 | $237.00K derived: sum of 3 quarters · filed 2026-08-31 | $313.00K 10-K · filed 2026-08-31 | ||||
| 2025-02-28 | $78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-13 | $156.00K derived: sum of 2 quarters · filed 2026-04-13 | $232.00K 10-Q · filed 2026-04-13 | $307.00K derived: sum of 4 quarters · filed 2026-04-13 | ||||
| 2024-11-30 | $78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-14 | $154.00K 10-Q · filed 2026-01-14 | $229.00K derived: sum of 3 quarters · filed 2026-01-14 | $303.00K derived: sum of 4 quarters · filed 2026-01-14 | ||||
| 2024-08-31 | $76.00K 10-Q · filed 2025-10-14 | $151.00K derived: sum of 2 quarters · filed 2025-10-14 | $225.00K derived: sum of 3 quarters · filed 2025-10-14 | $298.00K derived: sum of 4 quarters · filed 2025-10-14 | ||||
| 2024-05-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-29 | $149.00K derived: sum of 2 quarters · filed 2025-08-29 | $222.00K derived: sum of 3 quarters · filed 2025-08-29 | $293.00K 10-K · filed 2025-08-29 | ||||
| 2024-02-29 | $74.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-14 | $147.00K derived: sum of 2 quarters · filed 2025-04-14 | $218.00K 10-Q · filed 2025-04-14 | $283.00K derived: sum of 4 quarters · filed 2025-04-14 | ||||
| 2023-11-30 | $73.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-14 | $144.00K 10-Q · filed 2025-01-14 | $209.00K derived: sum of 3 quarters · filed 2025-01-14 | $277.00K derived: sum of 4 quarters · filed 2025-01-14 | ||||
| 2023-08-31 | $71.00K 10-Q · filed 2024-10-15 | $136.00K derived: sum of 2 quarters · filed 2024-10-15 | $204.00K derived: sum of 3 quarters · filed 2024-10-15 | $271.00K derived: sum of 4 quarters · filed 2024-10-15 | ||||
| 2023-05-31 | $65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-28 | $133.00K derived: sum of 2 quarters · filed 2024-08-28 | $200.00K derived: sum of 3 quarters · filed 2024-08-28 | $267.00K 10-K · filed 2024-08-28 | ||||
| 2023-02-28 | $68.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-12 | $135.00K derived: sum of 2 quarters · filed 2024-04-12 | $202.00K 10-Q · filed 2024-04-12 | $202.28K 10-Q · filed 2023-04-14 | $268.30K derived: sum of 4 quarters · filed 2024-04-12 | |||
| 2022-11-30 | $67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-16 | $134.00K 10-Q · filed 2024-01-16 | $134.47K 10-Q · filed 2023-01-13 | $200.30K derived: sum of 3 quarters · filed 2024-01-16 | $263.96K derived: sum of 4 quarters · filed 2024-01-16 | |||
| 2022-08-31 | $67.00K 10-Q · filed 2023-10-12 | $67.06K 10-Q · filed 2022-10-13 | $133.30K derived: sum of 2 quarters · filed 2023-10-12 | $196.96K derived: sum of 3 quarters · filed 2023-10-12 | $260.10K derived: sum of 4 quarters · filed 2023-10-12 | |||
| 2022-05-31 | $66.30K derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-25 | $129.96K derived: sum of 2 quarters · filed 2023-08-25 | $193.10K derived: sum of 3 quarters · filed 2023-08-25 | $256.00K 10-K · filed 2023-08-25 | $255.72K 10-K · filed 2022-08-29 | |||
| 2022-02-28 | $63.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-14 | $126.80K derived: sum of 2 quarters · filed 2023-04-14 | $189.70K 10-Q · filed 2023-04-14 | $253.37K derived: sum of 4 quarters · filed 2023-04-14 | ||||
| 2021-11-30 | $63.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-13 | $126.04K 10-Q · filed 2023-01-13 | $189.71K derived: sum of 3 quarters · filed 2023-01-13 | $248.60K derived: sum of 4 quarters · filed 2023-01-13 | ||||
| 2021-08-31 | $62.90K 10-Q · filed 2022-10-13 | $126.57K derived: sum of 2 quarters · filed 2022-10-13 | $185.46K derived: sum of 3 quarters · filed 2022-10-13 | |||||
| 2021-05-31 | $63.67K derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-29 | $122.56K derived: sum of 2 quarters · filed 2022-08-29 | $237.59K 10-K · filed 2022-08-29 | |||||
| 2021-02-28 | $58.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-14 | $173.92K 10-Q · filed 2022-04-14 | ||||||
| 2020-11-30 | $115.03K 10-Q · filed 2022-01-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |